Lindsey Scierka, MD MPH (@lscierkamd) 's Twitter Profile
Lindsey Scierka, MD MPH

@lscierkamd

T32 Vascular Outcomes Research Fellow with @YaleVAMOS at @YaleCardiology ❤️

ID: 1291407646420074497

calendar_today06-08-2020 16:15:57

29 Tweet

134 Followers

134 Following

Yale Cardiology (@yalecardiology) 's Twitter Profile Photo

Critical limb ischemia (CLI) hospitalization rates have been on the rise in the US. SCOPE-CLI aims to provide information to understand and address gaps in the quality of #cvPAD care. buff.ly/3gJQFdD Yale School of Medicine @nmcmill Yale Internal Medicine @MdScierka Carlos Mena Kim G. Smolderen, PhD

Yale Cardiology (@yalecardiology) 's Twitter Profile Photo

Critical limb ischemia is the most severe form of peripheral artery disease. A study by @MdScierka and Kim G. Smolderen, PhD aims to address the experiences, treatment preferences, and health status outcomes of these patients. buff.ly/3JV9pmP Yale School of Medicine Yale Internal Medicine Carlos Mena

Lindsey Scierka, MD MPH (@lscierkamd) 's Twitter Profile Photo

Mental health matters! Our recent YaleVAMOS meta-analysis found depression was associated with a 24% increased risk of all cause mortality in patients with PAD. Grateful for the support of my mentors Kim G. Smolderen, PhD and Carlos Mena #MindBody #T32 sciencedirect.com/science/articl…

YaleVAMOS (@yalevamos) 's Twitter Profile Photo

VAMOS T32 Fellow Focus: Scierka Highlights Link between Depression and Peripheral Artery Disease Outcomes m.yale.edu/8ry7 via Yale University CV Med Interested in T32 Post Doc opportunities? Contact us Lindsey Scierka, MD MPH Carlos Mena Yale Cardiology Yale Internal Medicine Kim G. Smolderen, PhD

Lindsey Scierka, MD MPH (@lscierkamd) 's Twitter Profile Photo

Great mentorship makes all the difference! My T32 experience has been instrumental in my development as a clinician researcher, reach out if you want to learn more! YaleVAMOS Carlos Mena Kim G. Smolderen, PhD

Lindsey Scierka, MD MPH (@lscierkamd) 's Twitter Profile Photo

Looking forward to traveling to the #ACC23 conference in New Orleans tomorrow, stay tuned to hear more about the work YaleVAMOS will presenting this year! #WCCardio #CardioTwitter #ACCFIT

Looking forward to traveling to the #ACC23 conference in New Orleans tomorrow, stay tuned to hear more about the work <a href="/YaleVAMOS/">YaleVAMOS</a> will presenting this year! 

#WCCardio #CardioTwitter #ACCFIT
Lindsey Scierka, MD MPH (@lscierkamd) 's Twitter Profile Photo

Excellent session on a global view of #PAD, highlighting a discussion of BEST-CLI results, a call to reduce non-traumatic amputations by 20% by 2030, and new PAD guidelines in the works for Fall 2023! #ACC23 American College of Cardiology

Excellent session on a global view of #PAD, highlighting a discussion of BEST-CLI results, a call to reduce non-traumatic amputations by 20% by 2030, and new PAD guidelines in the works for Fall 2023! #ACC23 <a href="/ACCinTouch/">American College of Cardiology</a>
Lindsey Scierka, MD MPH (@lscierkamd) 's Twitter Profile Photo

#ACC23 Day 2- Proud of the excellent work that has come out of the YaleVAMOS lab on validation of vascular registries, variability in GDMT, and health status profiles for patients with PAD Gaëlle Romain, PhD Jacob Cleman American College of Cardiology

#ACC23 Day 2- Proud of the excellent work that has come out of the <a href="/YaleVAMOS/">YaleVAMOS</a> lab on validation of vascular registries, variability in GDMT, and health status profiles for patients with PAD <a href="/GaelleRomain_Y/">Gaëlle Romain, PhD</a> <a href="/JacobCleman/">Jacob Cleman</a> <a href="/ACCinTouch/">American College of Cardiology</a>
Cesia Gallegos, MD MHS FASNC (@cesiagallegos) 's Twitter Profile Photo

This is my patient and his story is heartbreaking. Thank you Circulation Quality and Outcomes for amplifying his voice. We can do better for him. *Posted with patient’s permission (and at his request) ahajournals.org/doi/10.1161/CI…

This is my patient and his story is heartbreaking. Thank you <a href="/CircAHA/">Circulation</a> Quality and Outcomes for amplifying his voice. We can do better for him. 

*Posted with patient’s permission (and at his request) ahajournals.org/doi/10.1161/CI…